Brought to you by 
Cerevast, Lantheus sign deal for retinal vein occlusion device
04 Apr 2019
Executive Summary
Lantheus Holdings Inc. and Cerevast Medical Inc. are teaming up in the area of retinal vein occlusion (RVO).
Deal Industry
- Medical Devices
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Ultrasound
-
Diagnostic Imaging Equipment & Supplies
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cerevast, Lantheus sign deal for retinal vein occlusion device
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice